References
- Plasma Components. Circular of Information for the Use of Human Blood and Blood Components, AABB; America’s Blood Centers, American Red Cross, 2002.
- Standard 5.7.5.12. Standards for Blood Banks and Transfusion Services. 24th ed. Bethesda: AABB, 2006:30.
- Code of Federal Regulations, 21 CFR 640.34(a) and (b).
- United Kingdom Blood Transfusion Services/ National Institute for Biological Standards and Control, 2002.
- British Committee for Standards in Haematology. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br Soc Haematol 2004;126:11–28.
- Vassallo R. Issues to consider when converting frozen plasma into thawed plasma. AABB News 2007;9:16–7.
- Casper KK, Brooker M. Registry of Clotting Factor Concentrates, International Society on Thrombosis and Hemostasis, http://www.med.unc.edu/isth/ databases/clotting_factors/2006_registry_clotting_ factor_concentrates.pdf.
- Miller CH, Haff E, Platt SJ, et al. Measurement of von Willebrand factor activity: relative effects of ABO blood type and race. J Thromb Haemost 2003;1: 2191–7.
- Andrew M, Vegh P, Johnston, et al. Maturation of the hemostatic system during childhood. Blood 1992; 80:1998–2005.
- Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72:1651–7.
- Smith JF, Ness PM, Moroff G, Luban NLC. Retention of coagulation factors in plasma frozen after extended holding at 1–6°C. Vox Sang 2000;78: 28–30.
- O’Neill EM, Royley J, Hansson-Wicher M, et al. Effect of 24-hour whole-blood storage on plasma clotting factors. Transfusion 1999;39:488–91.
- Cardigan R, Lawrie AS, Mackie IJ, Williamson LM. The quality of fresh-frozen plasma produced form whole blood stored at 4°C overnight. Transfusion 2005;45:1342–8.
- Downes KA, Wilson E, Yomtovian R, Sarode R. Serial measurement of clotting factors in thawed plasma stored for 5 days. (Letter) Transfusion 2001;41:570.
- Sidhu RS, Le T, Brimhall B, Thompson H. Study of coagulation factor activities in apheresed thawed fresh frozen plasma at 1–6°C for five days. J Clin Apher 2006;21:224–6.
- Scott EA, Puca KE, Pietz BC, et al. Comparison and stability of ADAMTS13 activity in therapeutic plasma products. Transfusion 2007;47:1205.
- Runkel S, Haubelt H, Hitzler W, Hellstern P. The quality of plasma collected by automated apheresis and of recovered plasma from leukodepleted whole blood. Transfusion 2005;45:427–32.
- Nifong TP, Light J, Wenk RE. Coagulant stability and sterility of thawed S/D-treated plasma. Transfusion 2002;42:1581–4.
- Hellstern P, Haubelt H. Manufacture and composition of fresh frozen plasma and virus inactivated therapeutic plasma: correlation between composition and therapeutic efficacy. Thromb Res 2002;107(Suppl):S3–8.
- Williamson LM, Llewelyn CA, Fisher NC, et al. A randomised trial of solvent/detergent and standard fresh frozen plasma in the coagulopathy of liver disease and liver transplantation. Transfusion 1999; 39:1227–34.
- Haubelt H, Blome M, Kiessling AH, et al. Effects of solvent/detergent-treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgery. Vox Sang 2002;82: 9–14.
- Horowitz MS, Pehta JC. SD plasma in TTP and coagulation factor deficiencies for which no concentrates are available. Vox Sang 1998;74(Suppl 1):231–5.
- Alford BL. Important new drug warning (letter). Watertown, MA: Vitex Technologies, March 29, 2002.
- de Jonge J, Groenland THN, Metselaar HJ, et al. Fibrinolysis during liver transplantation is enhanced by using solvent/detergent virus-inactivated plasma (ESDEP). Anesth Analg 2002;94: 1127–31.
- Magner JJ, Crowley KJ, Boylan JF. Fatal fibrinolysis during orthotopic liver transplantation in patients receiving solvent/detergent-treated plasma (Octaplas). J Cardiothorac Vasc Anesth 2007;21: 410–3.
- Bostrom F, Sjodahl M, Wehlin L, et al. Coagulation parameters in apheresis and leukodepleted whole-blood plasma during storage. Transfusion 2007;47: 460–3.
- Palo R, Capraro L, Hovilehto S, et al. Population-based audit of fresh-frozen plasma transfusion practices. Transfusion 2006;46:1921–5.
- Wallis JP, Dzik WH. Is fresh frozen plasma overtransfused in the United States? (editorial). Transfusion 2004;44:1674–5.
- Dzik W, Rao A. Why do physicians request fresh frozen plasma? (Letter) Transfusion 2004;44:1393.
- Abdel-Wahab OI, Healy B, Dzik WH. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion 2006;46:1279–85.
- Stanworth SJ, Brunskill SJ, Hyde CJ, et al. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 2004;126:139–52.
- Strong DM, Lipton KS. Transfusion-related acute lung injury. AABB Association Bulletin #06–07, November 3, 2006. Bethesda: AABB.
- Triulzi DJ. The art of plasma transfusion therapy. Transfusion 2006;46:1268–70.
DOI: https://doi.org/10.21307/immunohematology-2019-333 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 150 - 157
Published on: Apr 1, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2020 A.F. Eder, M.A. Sebok, published by American National Red Cross
This work is licensed under the Creative Commons License.